Oct 20, 2026 07:14AM
Oct 2, 2026 09:30AM
Oct 2, 2026 09:30AM
Jun 11, 2026 07:00AM
Jun 11, 2026 07:00AM
Jun 5, 2026 07:00AM
Jun 5, 2026 07:00AM Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development
May 26, 2026 07:00AM
May 14, 2026 07:00AM
May 7, 2026 07:00AM
Apr 8, 2026 07:00AM
Apr 8, 2026 07:00AM
Apr 7, 2026 09:54AM
Apr 7, 2026 07:00AM Climb Bio receives FDA fast track designation for kidney disease drug
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM
Mar 5, 2026 07:00AM
Dec 31, 2025 04:15PM
Nov 6, 2025 07:01AM
Oct 21, 2025 07:00AM
Oct 21, 2025 07:00AM Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy
Oct 21, 2025 07:00AM
Oct 17, 2025 07:00AM
Oct 1, 2025 07:00AM
Oct 1, 2025 07:00AM
Sep 29, 2025 07:01AM
Sep 29, 2025 07:00AM
Sep 4, 2025 07:00AM Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
Aug 12, 2025 07:00AM
Jun 18, 2025 07:01AM
Jun 18, 2025 07:00AM
May 14, 2025 07:00AM
Apr 1, 2025 07:03AM
Apr 1, 2025 07:00AM
Mar 25, 2025 04:05PM Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates
Feb 24, 2025 07:04AM
Feb 24, 2025 07:00AM
Jan 9, 2025 07:00AM
Dec 19, 2024 07:03AM
Dec 19, 2024 07:00AM
Nov 12, 2024 04:05PM
Nov 11, 2024 07:00AM Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
Oct 15, 2024 07:00AM
Oct 2, 2024 09:01AM

1,201,822 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All